Clinical Trials of Biosimilars Should Become More Similar

Ann Rheum Dis. 2017 Jan;76(1):4-6. doi: 10.1136/annrheumdis-2015-208113. Epub 2016 Aug 25.

Abstract

No abstract available

Keywords: Anti-TNF; Disease Activity; Inflammation; Rheumatoid Arthritis; Treatment.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antirheumatic Agents*
  • Arthritis, Rheumatoid
  • Biosimilar Pharmaceuticals*
  • Infliximab
  • Tumor Necrosis Factor-alpha

Substances

  • Antirheumatic Agents
  • Biosimilar Pharmaceuticals
  • Tumor Necrosis Factor-alpha
  • Infliximab